Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Partow Kebriaei

Showing results (121-130 of 346) with videos related to

Pageof 35
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remissionBetul Oran, Uday Popat, Gabriella Rondon, et al.
Bone Marrow Transplantation|August 26, 2024
Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host diseaseCurtis M Marcoux, Amin M Alousi, Jin Im, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2020
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic LeukemiaGuillaume Richard-Carpentier, Elias Jabbour, Nicholas J Short, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2014
Comprehensive craniospinal radiation for controlling central nervous system leukemiaGary V Walker, Ferial Shihadeh, Hagop Kantarjian, et al.
Transplantation and Cellular Therapy|July 15, 2021
Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic MalignanciesXin Shelley Wang, Samer A Srour, Meagan Whisenant, et al.
Bone Marrow Transplantation|April 13, 2021
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortalityJeremy L Ramdial, Rohtesh S Mehta, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 7, 2013
Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantationLi Mei Poon, Amir Hamdi, Rima Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 4, 2012
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantationPartow Kebriaei, Roland Basset, C Ledesma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 5, 2013
Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myelomaKoji Sasaki, Gary Lu, Rima M Saliba, et al.
BMC Cancer|December 21, 2023
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplantOren Pasvolsky, Roland L Bassett, Sassine Ghanem, et al.
Pageof 35

Showing results (121-130 of 346) with videos related to

Sort By:
Pageof 35
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remissionBetul Oran, Uday Popat, Gabriella Rondon, et al.
Bone Marrow Transplantation|August 26, 2024
Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host diseaseCurtis M Marcoux, Amin M Alousi, Jin Im, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2020
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic LeukemiaGuillaume Richard-Carpentier, Elias Jabbour, Nicholas J Short, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2014
Comprehensive craniospinal radiation for controlling central nervous system leukemiaGary V Walker, Ferial Shihadeh, Hagop Kantarjian, et al.
Transplantation and Cellular Therapy|July 15, 2021
Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic MalignanciesXin Shelley Wang, Samer A Srour, Meagan Whisenant, et al.
Bone Marrow Transplantation|April 13, 2021
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortalityJeremy L Ramdial, Rohtesh S Mehta, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 7, 2013
Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantationLi Mei Poon, Amir Hamdi, Rima Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 4, 2012
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantationPartow Kebriaei, Roland Basset, C Ledesma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 5, 2013
Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myelomaKoji Sasaki, Gary Lu, Rima M Saliba, et al.
BMC Cancer|December 21, 2023
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplantOren Pasvolsky, Roland L Bassett, Sassine Ghanem, et al.
Pageof 35